Longitudinal multi-omics of host–microbe dynamics in prediabetes

Wenyu Zhou(Stanford University), M. Reza Sailani(Stanford University), Kévin Contrepois(Stanford University), Yanjiao Zhou(Jackson Laboratory), Sara Ahadi(Stanford University), Shana R. Leopold(Jackson Laboratory), Martin Jinye Zhang(Stanford University), Varsha Rao(Stanford University), Monika Avina(Stanford University), Tejaswini Mishra(Stanford University), Jethro S. Johnson(Jackson Laboratory), Brittany Lee‐McMullen(Stanford University), Songjie Chen(Stanford University), Ahmed A. Metwally(Stanford University), Thi Dong Binh Tran(Jackson Laboratory), Hoan Nguyen(Jackson Laboratory), Xin Zhou(Jackson Laboratory), Brandon Albright(Jackson Laboratory), Bo‐Young Hong(Jackson Laboratory), Lauren Petersen(Jackson Laboratory), Eddy J. Bautista(Jackson Laboratory), Blake Hanson(Jackson Laboratory), Lei Chen(Jackson Laboratory), Daniel Spakowicz(Jackson Laboratory), Amir Bahmani(Stanford Medicine), Denis Salins(Stanford University), Benjamin Leopold(Jackson Laboratory), Melanie Ashland(Stanford University), Orit Dagan‐Rosenfeld(Stanford University), Shannon Rego(Stanford University), Patricia Limcaoco(Stanford University), Elizabeth Colbert(Stanford University), Candice Allister(Stanford University), Dalia Perelman(Stanford University), Colleen Craig(Stanford University), Eric Wei(Stanford Medicine), Hassan Chaı̈b(Stanford Medicine), Daniel Hornburg(Stanford University), Jessilyn Dunn(Stanford University), Liang Liang(Stanford University), Sophia Miryam Schüssler‐Fiorenza Rose(VA Palo Alto Health Care System), Kim Kukurba(Stanford University), Brian Piening(Providence Portland Medical Center), Hannes Röst(University of Toronto), David Tse(Stanford University), Tracey McLaughlin(Stanford University), Erica Sodergren(Jackson Laboratory), George M. Weinstock(Jackson Laboratory), M Snyder(Stanford Medicine)
Nature
May 29, 2019
Cited by 602Open Access
Full Text

Abstract

Type 2 diabetes mellitus (T2D) is a growing health problem, but little is known about its early disease stages, its effects on biological processes or the transition to clinical T2D. To understand the earliest stages of T2D better, we obtained samples from 106 healthy individuals and individuals with prediabetes over approximately four years and performed deep profiling of transcriptomes, metabolomes, cytokines, and proteomes, as well as changes in the microbiome. This rich longitudinal data set revealed many insights: first, healthy profiles are distinct among individuals while displaying diverse patterns of intra- and/or inter-personal variability. Second, extensive host and microbial changes occur during respiratory viral infections and immunization, and immunization triggers potentially protective responses that are distinct from responses to respiratory viral infections. Moreover, during respiratory viral infections, insulin-resistant participants respond differently than insulin-sensitive participants. Third, global co-association analyses among the thousands of profiled molecules reveal specific host-microbe interactions that differ between insulin-resistant and insulin-sensitive individuals. Last, we identified early personal molecular signatures in one individual that preceded the onset of T2D, including the inflammation markers interleukin-1 receptor agonist (IL-1RA) and high-sensitivity C-reactive protein (CRP) paired with xenobiotic-induced immune signalling. Our study reveals insights into pathways and responses that differ between glucose-dysregulated and healthy individuals during health and disease and provides an open-access data resource to enable further research into healthy, prediabetic and T2D states.


Related Papers

No related papers found

Powered by citation graph analysis